CompletedPhase 2NCT00301782
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical Research Council
- Principal Investigator
- Robert A. Huddart, MDRoyal Marsden NHS Foundation Trust
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 88 enrolled
- Eligibility
- 16 years · MALE
- Timeline
- 2005 – 2010
Study locations (20)
- Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
- Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
- Addenbrooke's Hospital, Cambridge, England, United Kingdom
- Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham, England, United Kingdom
- Walsgrave Hospital, Coventry, England, United Kingdom
- Royal Devon and Exeter Hospital, Exeter, England, United Kingdom
- Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
- Leicester Royal Infirmary, Leicester, England, United Kingdom
- Saint Bartholomew's Hospital, London, England, United Kingdom
- University College of London Hospitals, London, England, United Kingdom
- Christie Hospital, Manchester, England, United Kingdom
- Clatterbridge Centre for Oncology, Merseyside, England, United Kingdom
- Nottingham City Hospital, Nottingham, England, United Kingdom
- Rosemere Cancer Centre at Royal Preston Hospital, Preston, England, United Kingdom
- Berkshire Cancer Centre at Royal Berkshire Hospital, Reading, England, United Kingdom
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00301782 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology